COVID-19:「アビガン」43か国に供与:大型連休後から:  COVID-19:Japan to send Avigan to 43 countries for coronavirus research:  COVID-19:日本将阿维甘送往43个国家进行冠状病毒研究

COVID-19:「アビガン」43か国に供与:大型連休後から: 
COVID-19:Japan to send Avigan to 43 countries for coronavirus research: 
COVID-19:日本将阿维甘送往43个国家进行冠状病毒研究

COVID-19:

茂木外務大臣:

記者会見で、これまでに80か国近くから提供を求める要請があります。

このうち43か国については大型連休後から国際機関を通じて順次、発送を始めることを明らかにしました

NHKニュース

https://www.google.co.jp/amp/s/www3.nhk.or.jp/news/html/20200501/amp/k10012413991000.html

Japan to send Avigan to 43 countries for coronavirus research

TOKYO (Kyodo) —

Japan will provide anti-flu drug Avigan free of charge to 43 countries for clinical studies on its efficacy as a coronavirus treatment, Foreign Minister Toshimitsu Motegi said Friday.

The drug is expected to be sent after the Golden Week holidays through May 6, Motegi said, a delay to his earlier projection that shipments could begin this week.

Some 80 countries have shown interest in Avigan,

Motegi previously saying arrangements have been made to send it to 38.

  1. Bangladesh,
  2. the Dominican Republic,
  3. Laos,
  4. Qatar and
  5. Uzbekistan

have since been added to the list of recipients, according to the Foreign Ministry.

Japan is paying for the initiative through a $1 million grant to the United Nations Office for Project Services, which will buy and distribute the drug.

Each country will receive enough to treat between 20 and 100 people for research purposes, Motegi said.

“We will cooperate with the private sector as well as the international community to develop a treatment” for coronavirus, he told a press conference.

Japan has been conducting clinical studies into Avigan after Chinese scientists suggested it had been effective in treating COVID-19 patients, especially those with mild symptoms.

The drug, also known as favipiravir, was developed by a subsidiary of Fujifilm Holdings Corp.

Japan plans to triple its stockpile of Avigan, enough to treat 2 million people, while China has said it will officially adopt it as part of its treatment guidelines for coronavirus.

As the drug is feared to cause birth defects, it cannot be used on pregnant women.

The Mainichi

https://mainichi.jp/english/articles/20200501/p2g/00m/0na/091000c